Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

The Prevalence of Intradialytic Hypotension in Patients on Conventional Hemodialysis: A Systematic Review with Meta-Analysis.

Kuipers J, Verboom LM, Ipema KJR, Paans W, Krijnen WP, Gaillard CAJM, Westerhuis R, Franssen CFM.

Am J Nephrol. 2019;49(6):497-506. doi: 10.1159/000500877. Epub 2019 May 24. Review.

2.

Association between quality of life and various aspects of intradialytic hypotension including patient-reported intradialytic symptom score.

Kuipers J, Oosterhuis JK, Paans W, Krijnen WP, Gaillard CAJM, Westerhuis R, Franssen CFM.

BMC Nephrol. 2019 May 14;20(1):164. doi: 10.1186/s12882-019-1366-2.

3.

Vancomycin pharmacokinetic model development in patients on intermittent online hemodiafiltration.

Westra N, Proost JH, Franssen CFM, Wilms EB, van Buren M, Touw DJ.

PLoS One. 2019 May 14;14(5):e0216801. doi: 10.1371/journal.pone.0216801. eCollection 2019.

4.

Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies.

Wiersema R, Castela Forte JN, Kaufmann T, de Haas RJ, Koster G, Hummel YM, Koeze J, Franssen CFM, Vos ME, Hiemstra B, Keus F, van der Horst ICC.

J Vis Exp. 2019 Jan 16;(143). doi: 10.3791/58802.

PMID:
30735183
5.

Changes in cerebral oxygenation and cerebral blood flow during hemodialysis - A simultaneous near-infrared spectroscopy and positron emission tomography study.

Polinder-Bos HA, Elting JWJ, Aries MJ, García DV, Willemsen AT, van Laar PJ, Kuipers J, Krijnen WP, Slart RH, Luurtsema G, Westerhuis R, Gansevoort RT, Gaillard CA, Franssen CF.

J Cereb Blood Flow Metab. 2018 Dec 12:271678X18818652. doi: 10.1177/0271678X18818652. [Epub ahead of print]

PMID:
30540219
6.

Complementary Biomarker Assessment of Components Absorbed from Diet and Creatinine Excretion Rate Reflecting Muscle Mass in Dialysis Patients.

Post A, Ozyilmaz A, Westerhuis R, Ipema KJR, Bakker SJL, Franssen CFM.

Nutrients. 2018 Nov 26;10(12). pii: E1827. doi: 10.3390/nu10121827.

7.

Plasma syndecan-1 in hemodialysis patients associates with survival and lower markers of volume status.

Koch J, Idzerda NMA, Dam W, Assa S, Franssen CFM, van den Born J.

Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F121-F127. doi: 10.1152/ajprenal.00252.2018. Epub 2018 Oct 31.

PMID:
30379102
8.

Longitudinal Associations Between Inflammation and Depressive Symptoms in Chronic Dialysis Patients.

Haverkamp GLG, Loosman WL, Schouten RW, Franssen CFM, Kema IP, van Diepen M, Dekker FW, Chandie Shaw PK, Smets YFC, Vleming LJ, van Jaarsveld BC, Honig A, Siegert CE.

Psychosom Med. 2019 Jan;81(1):74-80. doi: 10.1097/PSY.0000000000000649.

PMID:
30371633
9.

Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients.

Poppelaars F, Gaya da Costa M, Faria B, Berger SP, Assa S, Daha MR, Medina Pestana JO, van Son WJ, Franssen CFM, Seelen MA.

Front Immunol. 2018 Sep 13;9:2070. doi: 10.3389/fimmu.2018.02070. eCollection 2018.

10.

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients.

Hofman JMG, Eisenga MF, Diepenbroek A, Nolte IM, van Dam B, Westerhuis R, Bakker SJL, Franssen CFM, Gaillard CAJM.

BMC Nephrol. 2018 Sep 20;19(1):242. doi: 10.1186/s12882-018-1045-8.

11.

Publisher Correction: Lower body mass index and mortality in older adults starting dialysis.

Polinder-Bos HA, van Diepen M, Dekker FW, Hoogeveen EK, Franssen CFM, Gansevoort RT, Gaillard CAJM.

Sci Rep. 2018 Sep 18;8(1):14231. doi: 10.1038/s41598-018-32555-3.

12.

Lower body mass index and mortality in older adults starting dialysis.

Polinder-Bos HA, Diepen MV, Dekker FW, Hoogeveen EK, Franssen CFM, Gansevoort RT, Gaillard CAJM.

Sci Rep. 2018 Aug 27;8(1):12858. doi: 10.1038/s41598-018-30952-2. Erratum in: Sci Rep. 2018 Sep 18;8(1):14231.

13.

Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study.

Ettema EM, Kuipers J, van Faassen M, Groen H, van Roon AM, Lefrandt JD, Westerhuis R, Kema IP, van Goor H, Gansevoort RT, Gaillard CAJM, Franssen CFM.

BMC Nephrol. 2018 Aug 22;19(1):214. doi: 10.1186/s12882-018-0997-z.

14.

Renal sulfate reabsorption in healthy individuals and renal transplant recipients.

Post A, Minović I, van den Berg E, Eggersdorfer ML, Navis GJ, Geleijnse JM, Gans ROB, van Goor H, Struck J, Franssen CFM, Kema IP, Bakker SJL.

Physiol Rep. 2018 Apr;6(8):e13670. doi: 10.14814/phy2.13670.

15.

Hemodialysis Induces an Acute Decline in Cerebral Blood Flow in Elderly Patients.

Polinder-Bos HA, García DV, Kuipers J, Elting JWJ, Aries MJH, Krijnen WP, Groen H, Willemsen ATM, van Laar PJ, Strijkert F, Luurtsema G, Slart RHJA, Westerhuis R, Gansevoort RT, Gaillard CAJM, Franssen CFM.

J Am Soc Nephrol. 2018 Apr;29(4):1317-1325. doi: 10.1681/ASN.2017101088. Epub 2018 Mar 1. Erratum in: J Am Soc Nephrol. 2018 Aug;29(8):2256.

16.

The Complement System in Dialysis: A Forgotten Story?

Poppelaars F, Faria B, Gaya da Costa M, Franssen CFM, van Son WJ, Berger SP, Daha MR, Seelen MA.

Front Immunol. 2018 Jan 25;9:71. doi: 10.3389/fimmu.2018.00071. eCollection 2018. Review.

17.

Nephrotic syndrome due to lupus-like glomerulonephritis in an HIV-positive patient.

Wiegersma JS, Franssen CFM, Diepstra A.

Neth J Med. 2017 Nov;75(9):412-414.

18.

The Effect of Renal Function and Hemodialysis Treatment on Plasma Vasopressin and Copeptin Levels.

Ettema EM, Heida J, Casteleijn NF, Boesten L, Westerhuis R, Gaillard CAJM, Gansevoort RT, Franssen CFM, Zittema D.

Kidney Int Rep. 2017 Jan 23;2(3):410-419. doi: 10.1016/j.ekir.2017.01.006. eCollection 2017 May.

19.

Effect of isolated ultrafiltration and isovolemic dialysis on myocardial perfusion and left ventricular function assessed with 13N-NH3 positron emission tomography and echocardiography.

Assa S, Kuipers J, Ettema E, Gaillard CAJM, Krijnen WP, Hummel YM, Voors AA, van Melle JP, Westerhuis R, Willemsen A, Slart RHJA, Franssen CFM.

Am J Physiol Renal Physiol. 2018 Mar 1;314(3):F445-F452. doi: 10.1152/ajprenal.00368.2017. Epub 2017 Nov 8.

20.

Differences in the association of inflammation and tryptophan with depressive symptoms between white and non-white chronic dialysis patients.

Haverkamp GL, Loosman WL, Schouten RW, Franssen CF, Kema IP, van Diepen M, Dekker FW, Siegert CE, Honig A.

Gen Hosp Psychiatry. 2018 Jan - Feb;50:76-82. doi: 10.1016/j.genhosppsych.2017.10.003. Epub 2017 Oct 13.

PMID:
29065338
21.

The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.

de Vries LV, Minović I, Franssen CFM, van Faassen M, Sanders JS, Berger SP, Navis G, Kema IP, Bakker SJL.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F475-F486. doi: 10.1152/ajprenal.00690.2016. Epub 2017 May 10.

22.

Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.

Zittema D, Casteleijn NF, Bakker SJ, Boesten LS, Duit AA, Franssen CF, Gaillard CA, Gansevoort RT.

PLoS One. 2017 Jan 12;12(1):e0169263. doi: 10.1371/journal.pone.0169263. eCollection 2017.

23.

Investigation into cardiac sympathetic innervation during the commencement of haemodialysis in patients with chronic kidney disease.

Noordzij W, Özyilmaz A, Glaudemans AWJM, Tio RA, Goet ER, Franssen CFM, Slart RHJA.

Eur Radiol Exp. 2017;1(1):24. doi: 10.1186/s41747-017-0027-0. Epub 2017 Dec 6.

24.

Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.

Hempel JC, Poppelaars F, Gaya da Costa M, Franssen CF, de Vlaam TP, Daha MR, Berger SP, Seelen MA, Gaillard CA.

Am J Nephrol. 2017;45(1):49-59. doi: 10.1159/000451060. Epub 2016 Nov 26.

25.

Comparison of ex vivo stability of copeptin and vasopressin.

Heida JE, Boesten LSM, Ettema EM, Muller Kobold AC, Franssen CFM, Gansevoort RT, Zittema D.

Clin Chem Lab Med. 2017 Jun 27;55(7):984-992. doi: 10.1515/cclm-2016-0559.

PMID:
27879483
26.

Causes and Consequences of Interdialytic weight gain.

Ipema KJ, Kuipers J, Westerhuis R, Gaillard CA, van der Schans CP, Krijnen WP, Franssen CF.

Kidney Blood Press Res. 2016;41(5):710-720. Epub 2016 Oct 14.

27.

Erratum to: Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients.

Poppelaars F, Gaya da Costa M, Berger SP, Assa S, Meter-Arkema AH, Daha MR, van Son WJ, Franssen CF, Seelen MA.

J Transl Med. 2016 Aug 24;14(1):245. No abstract available.

28.

Strong predictive value of mannose-binding lectin levels for cardiovascular risk of hemodialysis patients.

Poppelaars F, Gaya da Costa M, Berger SP, Assa S, Meter-Arkema AH, Daha MR, van Son WJ, Franssen CF, Seelen MA.

J Transl Med. 2016 Aug 5;14(1):236. doi: 10.1186/s12967-016-0995-5. Erratum in: J Transl Med. 2016;14(1):245.

29.

Nutritional Status in Nocturnal Hemodialysis Patients - A Systematic Review with Meta-Analysis.

Ipema KJ, Struijk S, van der Velden A, Westerhuis R, van der Schans CP, Gaillard CA, Krijnen WP, Franssen CF.

PLoS One. 2016 Jun 20;11(6):e0157621. doi: 10.1371/journal.pone.0157621. eCollection 2016. Review.

30.

The role of tryptophan degradation in the association between inflammatory markers and depressive symptoms in chronic dialysis patients.

Haverkamp GL, Loosman WL, Franssen CF, Kema IP, van Diepen M, Dekker FW, Honig A, Siegert CE.

Nephrol Dial Transplant. 2017 Jun 1;32(6):1040-1047. doi: 10.1093/ndt/gfw212.

PMID:
27220752
31.

Gray matter volume and white matter lesions in chronic kidney disease: exploring the association with depressive symptoms.

Meurs M, Roest AM, Groenewold NA, Franssen CF, Westerhuis R, Kloppenburg WD, Doornbos B, Beukema L, Lindmäe H, de Groot JC, van Tol MJ, de Jonge P.

Gen Hosp Psychiatry. 2016 May-Jun;40:18-24. doi: 10.1016/j.genhosppsych.2016.02.005. Epub 2016 Mar 4.

PMID:
27040607
32.

Prevalence of intradialytic hypotension, clinical symptoms and nursing interventions--a three-months, prospective study of 3818 haemodialysis sessions.

Kuipers J, Oosterhuis JK, Krijnen WP, Dasselaar JJ, Gaillard CA, Westerhuis R, Franssen CF.

BMC Nephrol. 2016 Feb 27;17:21. doi: 10.1186/s12882-016-0231-9.

33.

Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis.

Ribitsch W, Schneditz D, Franssen CF, Schilcher G, Stadlbauer V, Horina JH, Rosenkranz AR.

PLoS One. 2015 Dec 29;10(12):e0145411. doi: 10.1371/journal.pone.0145411. eCollection 2015.

34.

Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.

Humalda JK, Riphagen IJ, Assa S, Hummel YM, Westerhuis R, Vervloet MG, Voors AA, Navis G, Franssen CF, de Borst MH; NIGRAM Consortium.

Nephrol Dial Transplant. 2016 Sep;31(9):1494-501. doi: 10.1093/ndt/gfv393. Epub 2015 Nov 24.

PMID:
26602863
35.

Thinking beyond the mass: ANCA-associated vasculitis mimicking a pancreatic malignancy.

De Bie AJ, Dekker MJ, Vermeulen Windsant IC, Nikkessen S, Demeyere TB, Konings CJ, de Hingh IH, Franssen CF, Creemers GJ.

Neth J Med. 2015 Aug;73(7):341-4.

36.

Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?

Ettema EM, Kuipers J, Assa S, Bakker SJ, Groen H, Westerhuis R, Gaillard CA, Gansevoort RT, Franssen CF.

PLoS One. 2015 May 14;10(5):e0127116. doi: 10.1371/journal.pone.0127116. eCollection 2015.

37.

In reply to 'Intravenous iron, inflammation, and ventricular dysfunction during hemodialysis'.

Assa S, Westerhuis R, Franssen CF.

Am J Kidney Dis. 2015 Mar;65(3):518-9. doi: 10.1053/j.ajkd.2014.11.029. No abstract available.

PMID:
25704044
38.

Effect of nocturnal haemodialysis on body composition.

Ipema KJ, Westerhuis R, van der Schans CP, de Jong PE, Gaillard CA, Krijnen WP, Slart RH, Franssen CF.

Nephron Clin Pract. 2014;128(1-2):171-7. doi: 10.1159/000368239. Epub 2014 Nov 6.

PMID:
25376526
39.

Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis.

Meijers WC, van der Velde AR, Ruifrok WP, Schroten NF, Dokter MM, Damman K, Assa S, Franssen CF, Gansevoort RT, van Gilst WH, Silljé HH, de Boer RA.

J Am Heart Assoc. 2014 Sep 18;3(5):e000962. doi: 10.1161/JAHA.114.000962.

40.

Kidney function and plasma copeptin levels in healthy kidney donors and autosomal dominant polycystic kidney disease patients.

Zittema D, van den Berg E, Meijer E, Boertien WE, Muller Kobold AC, Franssen CF, de Jong PE, Bakker SJ, Navis G, Gansevoort RT.

Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1553-62. doi: 10.2215/CJN.08690813. Epub 2014 Jul 3.

41.

Dialysis hypotension: a role for inadequate increase in arginine vasopressin levels? A systematic literature review and meta-analysis.

Ettema EM, Zittema D, Kuipers J, Gansevoort RT, Vart P, de Jong PE, Westerhuis R, Franssen CF.

Am J Nephrol. 2014;39(2):100-9. doi: 10.1159/000358203. Epub 2014 Feb 6. Review.

42.

Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients.

Suttorp MM, Hoekstra T, Mittelman M, Ott I, Franssen CF, Dekker FW.

PLoS One. 2013 Dec 31;8(12):e84848. doi: 10.1371/journal.pone.0084848. eCollection 2013.

43.

Hemodialysis-induced regional left ventricular systolic dysfunction and inflammation: a cross-sectional study.

Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, Groen H, Bakker SJ, Muller Kobold AC, van Oeveren W, Struck J, de Jong PE, Franssen CF.

Am J Kidney Dis. 2014 Aug;64(2):265-73. doi: 10.1053/j.ajkd.2013.11.010. Epub 2013 Dec 21.

PMID:
24364893
44.

Variability of predialytic, intradialytic, and postdialytic blood pressures in the course of a week: a study of Dutch and US maintenance hemodialysis patients.

Kuipers J, Usvyat LA, Oosterhuis JK, Dasselaar JJ, de Jong PE, Westerhuis R, Sands JJ, Wang Y, Kotanko P, Franssen CF.

Am J Kidney Dis. 2013 Oct;62(4):779-88. doi: 10.1053/j.ajkd.2013.03.034. Epub 2013 Jun 4.

PMID:
23759298
45.

Changes in left ventricular diastolic function during hemodialysis sessions.

Assa S, Hummel YM, Voors AA, Kuipers J, Groen H, de Jong PE, Westerhuis R, Franssen CF.

Am J Kidney Dis. 2013 Sep;62(3):549-56. doi: 10.1053/j.ajkd.2013.02.356. Epub 2013 Mar 30.

PMID:
23548554
46.

Chronic kidney disease: RAAS blockade and diastolic heart failure in chronic kidney disease.

Franssen CF, Navis G.

Nat Rev Nephrol. 2013 Apr;9(4):190-2. doi: 10.1038/nrneph.2013.39. Epub 2013 Mar 12. No abstract available.

PMID:
23478414
47.

Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients.

Assa S, Gansevoort RT, Westerhuis R, Kobold AC, Voors AA, de Jong PE, Bakker SJ, Franssen CF.

Clin Res Cardiol. 2013 Jun;102(6):439-45. doi: 10.1007/s00392-013-0551-8. Epub 2013 Feb 9.

PMID:
23397594
48.

Dialysis hypotension and vasopressin.

Ettema EM, Franssen CF.

Nefrologia. 2012;32(5):679. doi: 10.3265/Nefrologia.pre2012.Jun.11541. No abstract available.

49.

Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.

Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, de Jong PE, Franssen CF.

Clin J Am Soc Nephrol. 2012 Oct;7(10):1615-23. doi: 10.2215/CJN.00850112. Epub 2012 Jul 19.

50.

Vasopressin, copeptin, and renal concentrating capacity in patients with autosomal dominant polycystic kidney disease without renal impairment.

Zittema D, Boertien WE, van Beek AP, Dullaart RP, Franssen CF, de Jong PE, Meijer E, Gansevoort RT.

Clin J Am Soc Nephrol. 2012 Jun;7(6):906-13. doi: 10.2215/CJN.11311111. Epub 2012 Apr 19.

Supplemental Content

Loading ...
Support Center